Is it Getting Breezy In Here? Biotech IPO Climate Improving
This article was originally published in Start Up
Executive Summary
Don't look now, biotech IPO prices are getting better. But VCs still prefer M&A. Here's a look at biotech IPOs from the past two years: average cash raised, total cash raised and total successful IPOs.